CTOs on the Move

Apos Therapy

www.apostherapy.com

 
AposTherapy provides a clinically proven, innovative, drug-free, at-home treatment for reducing pain and improving function in patients suffering from knee osteoarthritis and chronic lower back or hip pain.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Apos Therapy raised $11M on 02/17/2020

Similar Companies

Hovione Ltd

Hovione Ltd is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in East Windsor, NJ. To find more information about Hovione Ltd, please visit www.hovione.com

Bioforum The Data Masters

Bioforum is a data focused CRO, offering a wide range of consulting services, medical writing, data management and bio-statistical support. We are a multi disciplinary team of experts that helps clients comprehend the value of their clinical data simply by making it readily available for monitoring, analysis and ready for submission. Adhering To The Highest Quality We simply don`t compromise on quality. Through our quality management system we ensure both processes and deliverables meet the industry standards and customer requirements. We implement high-quality practices in any project and task we perform and seek continuous improvement.

eSOLUTIONS, Inc.

eSOLUTIONS, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

MWDN

MWDN Ltd is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Naveos

NAVEOS® is the proven leader in maximizing the value of governmental program reimbursements for healthcare providers. Since 2005, our superior approach to data analytics has enabled healthcare providers to realize almost one billion dollars in additional DSH/340B reimbursement payments. NAVEOS® has developed a fully integrated DSH/340B software solution with a national eligibility verification network for both Medicare and Medicaid data. This system, which is the most robust in the industry, uses sophisticated algorithms to match eligibility data with patient data, applies the most up to date Federal and State regulatory parameters, then builds comprehensive deliverables for supporting DSH/340B filings. By leveraging our state-of-the-art technology and unsurpassed domain expertise, we generate best-in-class deliverables that yield impressive value and achieve a stellar (99.7%) audit acceptance rate.